Similarly, it has been shown that Twist1 (a master regulator of EMT) is associated with multi-drug resistance in breast cancer, however, the mechanism by which Twist1 leads to resistance was not explored (Li et al., 2009). This evidence concerns the gene TWIST1 and breast carcinoma.